Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN)

CUSIP: 59045L106

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
-16,105,576
Put/Call ratio
587%
SEC-reported price per share
$1.43
Number of holders
129
Value change
-$24,954,008
Number of buys
52
Open additional details 1 more signal available
Number of sells
53
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,992,318

Security key

59045L106

Report period

Q4 2024

Institutions

129

Top holders

10

Ownership snapshot

Top reported holders of MRSN - Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Nextech Crossover I GP S....
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
15/15
Latest evidence
20 Dec 2024
13D/G 13F 3/4/5 Lead comparable stake: 10% 13D/G row: Nextech Crossover I GP S.a r.l. Showing 1-6 of 15 holder rows.

Quick read

Nextech Crossover I GP S.a r.l. leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Nextech Crossover I GP S.a r.l.'s linked filing trail.
Comparable ownership Top 5
Nextech Crossover I GP S.a r.l. 10%
EcoR1 Capital, LLC 388%
Nextech Invest Ltd. 242%
Venrock Adviser, LLC 227%
Bain Capital Life Sciences Invest... 174%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Nextech Crossover I GP S.a r.l.
13D/G
10%
$4,344,209
12,067,246 shares
$0 20 Dec 2024
EcoR1 Capital, LLC
13F 3/4/5
Company · 10%+ Owner
388%
$36,599,260
19,364,688 shares
30 Sep 2024
Nextech Invest Ltd.
13F
Company
13F
242%
$22,807,095
12,067,246 shares
30 Sep 2024
Venrock Adviser, LLC
13F
Company
13F
227%
$21,409,920
11,328,000 shares
30 Sep 2024
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
174%
$16,374,342
8,663,673 shares
30 Sep 2024
BlackRock, Inc.
13F
Company
13F
173%
$16,295,319
8,621,861 shares
30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
129
Shares
104,303,178
Rows available
129
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q4 2025 Across Filers

Q4 2025 holders
3
Q4 2024 holders
129
Holder diff
126
Investor Q4 2025 Shares Q4 2024 Shares Share Diff Share Chg % Q4 2025 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .